Loading clinical trials...
Loading clinical trials...
Phase II Trial of Cetuximab Plus Cisplatin, 5- Fluorouracil and Radiation in Immunocompetent Patients With Anal Carcinoma
Conditions
Interventions
cetuximab
cisplatin
+2 more
Locations
125
United States
Stanford Cancer Center
Stanford, California, United States
Poudre Valley Hospital
Fort Collins, Colorado, United States
Front Range Cancer Specialists
Fort Collins, Colorado, United States
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
Hematology and Oncology Associates
Chicago, Illinois, United States
Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
Start Date
February 28, 2007
Primary Completion Date
November 1, 2015
Completion Date
August 17, 2021
Last Updated
June 29, 2023
NCT04929028
NCT05639972
NCT06640283
NCT05040815
NCT06366841
NCT06327568
Lead Sponsor
ECOG-ACRIN Cancer Research Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions